Accessibility Menu
 
Arcadia Biosciences logo

Arcadia Biosciences

(NASDAQ) RKDA

Current Price$1.05
Market Cap$2.18M
Since IPO (2015)-100%
5 Year-99%
1 Year-68%
1 Month-18%

Arcadia Biosciences Financials at a Glance

Market Cap

$2.18M

Revenue (TTM)

$4.86M

Net Income (TTM)

$2.34M

EPS (TTM)

$-1.71

P/E Ratio

-0.62

Dividend

$0.00

Beta (Volatility)

0.87 (Low)

Price

$1.05

Volume

2

Open

$1.05

Previous Close

$1.05

Daily Range

$1.05 - $1.05

52-Week Range

$0.89 - $6.71

RKDA News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Arcadia Biosciences

Industry

Food Products

Employees

8

CEO

Thomas J. Schaefer, CFA, MBA

Headquarters

Davis, CA 95618, US

RKDA Financials

Key Financial Metrics (TTM)

Gross Margin

36%

Operating Margin

-51%

Net Income Margin

-48%

Return on Equity

-45%

Return on Capital

-56%

Return on Assets

-36%

Earnings Yield

-1.61%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.18M

Shares Outstanding

2.06M

Volume

2

Avg. Volume

31.58K

Financials (TTM)

Gross Profit

$1.76M

Operating Income

$9.99M

EBITDA

$9.84M

Operating Cash Flow

$4.74M

Capital Expenditure

$0.00

Free Cash Flow

$4.74M

Cash & ST Invst.

$4.56M

Total Debt

$0.00

Arcadia Biosciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$901.00K

-25.9%

Gross Profit

$192.00K

-50.6%

Gross Margin

21.31%

N/A

Market Cap

$2.18M

N/A

Market Cap/Employee

$242.26K

N/A

Employees

9

N/A

Net Income

$1.34M

+67.1%

EBITDA

$1.38M

+39.0%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$4.56M

+11.6%

Accounts Receivable

$425.00K

-63.8%

Inventory

$1.21M

+34.1%

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

-100.0%

Return on Assets

-35.73%

N/A

Return on Invested Capital

-55.67%

N/A

Free Cash Flow

$861.00K

+61.0%

Operating Cash Flow

$861.00K

+61.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CAPSCapstone Holding Corp.
$0.39+2.68%
CNEYCN Energy Group. Inc.
$0.68+3.19%
RETOReTo Eco-Solutions, Inc.
$0.60-4.78%
ENFYEnlightify Inc.
$0.01+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$12.91+0.04%
SOFISoFi Technologies
$16.10+0.04%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.63+0.10%
MARAMara Holdings
$11.99+0.12%

Questions About RKDA

What is the current price of Arcadia Biosciences?

Arcadia Biosciences is trading at $1.05 per share.

What is the 52-week range for Arcadia Biosciences?

Over the past 52 weeks, Arcadia Biosciences has traded between $0.89 and $6.71.

How much debt does Arcadia Biosciences have?

As of the most recent reporting period, Arcadia Biosciences reported total debt of N/A.

How much cash does Arcadia Biosciences have on hand?

Arcadia Biosciences reported $259,000 in cash and cash equivalents in its most recent financial results.

What is Arcadia Biosciences’s dividend yield?

Arcadia Biosciences does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.